首页> 外文期刊>Free Radical Biology and Medicine: The Official Journal of the Oxygen Society >(-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68.
【24h】

(-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68.

机译:(-)-Epigallocatechin-3-gallate通过靶向DEAD-box RNA解旋酶p68抑制AZ521人胃癌细胞的生长。

获取原文
获取原文并翻译 | 示例
       

摘要

(-)-Epigallocatechin-3-gallate (EGCG), the most abundant and biologically active polyphenol in green tea, induces apoptosis and suppresses proliferation of cancer cells by modulating multiple signal transduction pathways. However, the fundamental mechanisms responsible for these cancer-preventive effects have not been clearly elucidated. Recently, we found that EGCG can covalently bind to cysteine residues in proteins through autoxidation and subsequently modulate protein function. In this study, we demonstrate the direct binding of EGCG to cellular proteins in AZ521 human gastric cancer cells by redox-cycle staining. We comprehensively explored the binding targets of EGCG from EGCG-treated AZ521 cells by proteomics techniques combined with the boronate-affinity pull-down method. The DEAD-box RNA helicase p68, which is overexpressed in a variety of tumor cells and plays an important role in cancer development and progression, was identified as a novel EGCG-binding target. Exposure of AZ521 cells to EGCG lowered the p68 level dose dependently. The present findings show that EGCG inhibits AZ521 cell proliferation by preventing beta-catenin oncogenic signaling through proteasomal degradation of p68 and provide a new perspective on the molecular mechanism of EGCG action.
机译:(-)-Epigallocatechin-3-gallate(EGCG)是绿茶中含量最丰富且具有生物活性的多酚,可通过调节多种信号转导途径诱导细胞凋亡并抑制癌细胞的增殖。但是,尚未明确阐明造成这些癌症预防作用的基本机制。最近,我们发现EGCG可通过自氧化共价结合蛋白质中的半胱氨酸残基,并随后调节蛋白质功能。在这项研究中,我们通过氧化还原循环染色证明了EGCG与AZ521人胃癌细胞中细胞蛋白的直接结合。我们通过蛋白质组学技术结合硼酸亲和下拉法,全面研究了EGCG处理的AZ521细胞中EGCG的结合靶点。 DEAD-box RNA解旋酶p68在多种肿瘤细胞中过表达,并且在癌症的发展和进程中起着重要作用,被确定为新型EGCG结合靶标。 AZ521细胞暴露于EGCG可以降低p68水平剂量。本研究结果表明,EGCG通过阻止p68的蛋白酶体降解,阻止β-catenin致癌信号传导,从而抑制AZ521细胞的增殖,并为EGCG作用的分子机制提供了新的视角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号